GLP-1 medications

UK Probes Suicide Risk of Popular Diabetes Drugs

The UK is looking into GLP-1 medications made by Novo Nordisk, AstraZeneca, Lilly, and Sanofi for GLP-1 inhibitor suicide risk

SG Tylor

Following the European Union’s lead, the United Kingdom has initiated an investigation into the potential suicide risks associated with popular ...